AYTU BIOPHARMA, INC Increase (Decrease) in Accounts Payable and Accrued Liabilities
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$4.52 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2020-11-12
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-09-30 was -$4.52M, a 1732.11% decline year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-06-30 was $3.54M, a 984.23% increase year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-03-31 was -$7.72M.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-12-31 was $2.53M, a 873.09% increase year-over-year.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was -$1.38M, a 1121.35% decline from fiscal 2019.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $134.78K.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was -$109.71K, a 122.24% decline from fiscal 2017.
- AYTU BIOPHARMA, INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $493.22K, a 29.36% decline from fiscal 2016.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 81 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 84 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 87 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 90 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 93 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 96 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 99 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 102 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 105 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 108 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | -$4.52M 10-Q · filed 2020-11-12 | -$983.88K derived: sum of 2 quarters · filed 2020-11-12 | -$8.70M derived: sum of 3 quarters · filed 2020-11-12 | -$6.17M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2020-06-30 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | -$4.18M derived: sum of 2 quarters · filed 2020-10-06 | -$1.65M derived: sum of 3 quarters · filed 2020-10-06 | -$1.38M 10-K · filed 2020-10-06 | |||||||||||||||
| 2020-03-31 | -$7.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | -$5.19M derived: sum of 2 quarters · filed 2020-05-15 | -$4.91M 10-Q · filed 2020-05-15 | -$4.59M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2019-12-31 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $2.81M 10-Q · filed 2020-02-14 | $3.13M derived: sum of 3 quarters · filed 2020-11-12 | $2.69M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2019-09-30 | $276.92K 10-Q · filed 2020-11-12 | $603.02K derived: sum of 2 quarters · filed 2020-11-12 | $159.58K derived: sum of 3 quarters · filed 2020-11-12 | $419.58K derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2019-06-30 | $326.11K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | -$117.34K derived: sum of 2 quarters · filed 2020-10-06 | $142.66K derived: sum of 3 quarters · filed 2020-10-06 | $134.78K 10-K · filed 2020-10-06 | |||||||||||||||
| 2019-03-31 | -$443.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | -$183.44K derived: sum of 2 quarters · filed 2020-05-15 | -$191.33K 10-Q · filed 2020-05-15 | -$17.77K 10-Q · filed 2019-05-14 | -$1.27M derived: sum of 4 quarters · filed 2020-05-15 | ||||||||||||||
| 2018-12-31 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $252.11K 10-Q · filed 2020-02-14 | -$825.24K derived: sum of 3 quarters · filed 2020-02-14 | -$982.15K derived: sum of 4 quarters · filed 2020-02-14 | |||||||||||||||
| 2018-09-30 | -$7.89K 10-Q · filed 2019-11-14 | -$1.09M derived: sum of 2 quarters · filed 2019-11-14 | -$1.24M derived: sum of 3 quarters · filed 2019-11-14 | $442.04K derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||||
| 2018-06-30 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$1.23M derived: sum of 2 quarters · filed 2019-09-26 | $449.93K derived: sum of 3 quarters · filed 2019-09-26 | -$109.71K 10-K · filed 2019-09-26 | |||||||||||||||
| 2018-03-31 | -$156.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $1.53M derived: sum of 2 quarters · filed 2019-05-14 | $967.64K 10-Q · filed 2019-05-14 | $1.77M derived: sum of 4 quarters · filed 2019-05-14 | |||||||||||||||
| 2017-12-31 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | $1.12M 10-Q · filed 2019-05-14 | $1.93M derived: sum of 3 quarters · filed 2019-05-14 | $1.81M derived: sum of 4 quarters · filed 2019-05-14 | |||||||||||||||
| 2017-09-30 | -$559.64K 10-Q · filed 2018-11-07 | $241.44K derived: sum of 2 quarters · filed 2018-11-07 | $129.42K derived: sum of 3 quarters · filed 2018-11-07 | $42.95K derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||||
| 2017-06-30 | $801.07K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $689.05K derived: sum of 2 quarters · filed 2018-09-06 | $602.58K derived: sum of 3 quarters · filed 2018-09-06 | $493.22K 10-K · filed 2018-09-06 | |||||||||||||||
| 2017-03-31 | -$112.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$198.49K derived: sum of 2 quarters · filed 2018-05-14 | -$307.85K 10-Q · filed 2018-05-14 | $340.33K derived: sum of 4 quarters · filed 2018-05-14 | |||||||||||||||
| 2016-12-31 | -$86.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$195.84K 10-Q · filed 2018-02-08 | -$434.23K 10-Q · filed 2017-02-09 | $452.35K derived: sum of 3 quarters · filed 2018-02-08 | $629.18K derived: sum of 4 quarters · filed 2018-02-08 | ||||||||||||||
| 2016-09-30 | -$109.36K 10-Q · filed 2017-11-09 | -$607.88K 10-Q · filed 2016-11-07 | $538.82K derived: sum of 2 quarters · filed 2017-11-09 | $715.65K derived: sum of 3 quarters · filed 2017-11-09 | $710.56K derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||||
| 2016-06-30 | $648.18K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $825.02K derived: sum of 2 quarters · filed 2017-08-31 | $819.92K derived: sum of 3 quarters · filed 2017-08-31 | $698.24K 10-K · filed 2017-08-31 | $1.62M 10-K · filed 2016-09-01 | ||||||||||||||
| 2016-03-31 | $176.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $171.74K derived: sum of 2 quarters · filed 2017-05-11 | $50.05K 10-Q · filed 2017-05-11 | -$18.32K 10-Q · filed 2016-05-11 | $700.52K derived: sum of 4 quarters · filed 2017-05-11 | ||||||||||||||
| 2015-12-31 | -$5.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$126.78K 10-Q · filed 2017-02-09 | $523.69K derived: sum of 3 quarters · filed 2017-02-09 | $719.21K derived: sum of 4 quarters · filed 2017-02-09 | |||||||||||||||
| 2015-09-30 | -$121.68K 10-Q · filed 2016-11-07 | $0.00 10-Q · filed 2015-11-06 | $528.79K derived: sum of 2 quarters · filed 2016-11-07 | $724.31K derived: sum of 3 quarters · filed 2016-11-07 | |||||||||||||||
| 2015-06-30 | $650.47K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $845.99K derived: sum of 2 quarters · filed 2016-09-01 | $547.31K 10-K · filed 2016-09-01 | ||||||||||||||||
| 2015-03-31 | $195.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | -$103.16K 10-Q · filed 2016-05-11 | |||||||||||||||||
| 2015-02-28 | $1.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $4.89K 10-Q · filed 2015-04-15 | |||||||||||||||||
| 2014-12-31 | -$162.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | -$298.68K 10-Q · filed 2016-02-11 | |||||||||||||||||
| 2014-11-30 | $3.73K 10-Q · filed 2015-01-12 | ||||||||||||||||||
| 2014-09-30 | -$136.19K 10-Q · filed 2015-11-06 | ||||||||||||||||||
| 2014-05-31 | -$19.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | -$7.42K derived: sum of 2 quarters · filed 2015-04-15 | -$2.00 10-Q · filed 2014-07-10 | $1.70K derived: sum of 4 quarters · filed 2015-04-15 | $27.93K 10-Q · filed 2014-07-10 | ||||||||||||||
| 2014-02-28 | $11.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $19.41K 10-Q · filed 2015-04-15 | $21.11K derived: sum of 3 quarters · filed 2015-04-15 | $15.80K derived: sum of 4 quarters · filed 2015-04-15 | $47.34K 10-Q · filed 2014-04-11 | ||||||||||||||
| 2013-11-30 | $7.42K 10-Q · filed 2015-01-12 | $9.13K derived: sum of 2 quarters · filed 2015-01-12 | $3.81K derived: sum of 3 quarters · filed 2015-01-12 | $6.89K derived: sum of 4 quarters · filed 2015-01-12 | $35.35K 10-Q · filed 2014-01-10 | ||||||||||||||
| 2013-08-31 | $1.71K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | -$3.61K derived: sum of 2 quarters · filed 2014-11-26 | -$527.00 derived: sum of 3 quarters · filed 2014-11-26 | $6.70K 10-K · filed 2014-11-26 | $27.93K 10-K · filed 2014-11-26 | ||||||||||||||
| 2013-05-31 | -$5.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | -$2.23K derived: sum of 2 quarters · filed 2014-07-10 | $5.00K 10-Q · filed 2014-07-10 | $5.78K derived: sum of 4 quarters · filed 2014-11-26 | $26.22K 10-Q · filed 2013-06-28 | ||||||||||||||
| 2013-02-28 | $3.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-11 | $10.31K 10-Q · filed 2014-04-11 | $11.09K derived: sum of 3 quarters · filed 2014-11-26 | $13.93K derived: sum of 4 quarters · filed 2014-11-26 | $31.54K 10-Q · filed 2013-04-15 | ||||||||||||||
| 2012-11-30 | $7.23K 10-Q · filed 2014-01-10 | $8.01K derived: sum of 2 quarters · filed 2014-11-26 | $10.85K derived: sum of 3 quarters · filed 2014-11-26 | $10.15K derived: sum of 4 quarters · filed 2014-11-26 | $28.46K 10-Q · filed 2013-01-14 | ||||||||||||||
| 2012-08-31 | $784.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $3.62K derived: sum of 2 quarters · filed 2014-11-26 | $2.92K derived: sum of 3 quarters · filed 2014-11-26 | $8.18K 10-K · filed 2014-11-26 | $21.23K 10-K · filed 2012-11-29 | ||||||||||||||
| 2012-05-31 | $2.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | $2.13K derived: sum of 2 quarters · filed 2013-06-28 | $7.39K 10-Q · filed 2013-06-28 | $5.60K derived: sum of 4 quarters · filed 2013-06-28 | $20.44K 10-Q · filed 2012-06-26 | ||||||||||||||
| 2012-02-29 | -$702.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | $4.56K 10-Q · filed 2013-04-15 | $2.77K derived: sum of 3 quarters · filed 2013-04-15 | $4.38K derived: sum of 4 quarters · filed 2013-04-15 | $17.61K 10-Q · filed 2012-04-12 | ||||||||||||||
| 2011-11-30 | $5.26K 10-Q · filed 2013-01-14 | $3.47K derived: sum of 2 quarters · filed 2013-01-14 | $5.09K derived: sum of 3 quarters · filed 2013-01-14 | $2.83K derived: sum of 4 quarters · filed 2013-01-14 | $18.31K 10-Q · filed 2011-12-23 | ||||||||||||||
| 2011-08-31 | -$1.79K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | -$176.00 derived: sum of 2 quarters · filed 2012-11-29 | -$2.43K derived: sum of 3 quarters · filed 2012-11-29 | $1.03K 10-K · filed 2012-11-29 | |||||||||||||||
| 2011-05-31 | $1.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | -$637.00 derived: sum of 2 quarters · filed 2012-06-26 | $2.83K 10-Q · filed 2012-06-26 | ||||||||||||||||
| 2011-02-28 | -$2.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | $1.21K 10-Q · filed 2012-04-12 | |||||||||||||||||
| 2010-11-30 | $3.46K 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |